252 related articles for article (PubMed ID: 36031998)
21. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa.
Wang L; Cheng G
J Med Virol; 2022 Apr; 94(4):1728-1733. PubMed ID: 34897752
[TBL] [Abstract][Full Text] [Related]
22. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study.
Cloete J; Kruger A; Masha M; du Plessis NM; Mawela D; Tshukudu M; Manyane T; Komane L; Venter M; Jassat W; Goga A; Feucht U
Lancet Child Adolesc Health; 2022 May; 6(5):294-302. PubMed ID: 35189083
[TBL] [Abstract][Full Text] [Related]
23. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.
Suzuki R; Yamasoba D; Kimura I; Wang L; Kishimoto M; Ito J; Morioka Y; Nao N; Nasser H; Uriu K; Kosugi Y; Tsuda M; Orba Y; Sasaki M; Shimizu R; Kawabata R; Yoshimatsu K; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; ; Sawa H; Ikeda T; Irie T; Matsuno K; Tanaka S; Fukuhara T; Sato K
Nature; 2022 Mar; 603(7902):700-705. PubMed ID: 35104835
[TBL] [Abstract][Full Text] [Related]
24. COVID-19 pandemic dynamics in South Africa and epidemiological characteristics of three variants of concern (Beta, Delta, and Omicron).
Yang W; Shaman J
medRxiv; 2022 Jun; ():. PubMed ID: 34981071
[TBL] [Abstract][Full Text] [Related]
25. SARS-COV-2 Variants: Differences and Potential of Immune Evasion.
Hirabara SM; Serdan TDA; Gorjao R; Masi LN; Pithon-Curi TC; Covas DT; Curi R; Durigon EL
Front Cell Infect Microbiol; 2021; 11():781429. PubMed ID: 35118007
[TBL] [Abstract][Full Text] [Related]
26. [Omicron Variant of SARS-CoV-2 and Its Potential Impact on Dental Practice].
Ren B; Liao BY; Wang JN; Peng X; Zhou XD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 53(2):175-180. PubMed ID: 35332714
[TBL] [Abstract][Full Text] [Related]
27. Infectivity versus fatality of SARS-CoV-2 mutations and influenza.
Xue L; Jing S; Zhang K; Milne R; Wang H
Int J Infect Dis; 2022 Aug; 121():195-202. PubMed ID: 35584743
[TBL] [Abstract][Full Text] [Related]
28. Omicron: the highly mutational COVID-19 variant with immune escape.
Khajotia R
Pan Afr Med J; 2022; 41():84. PubMed ID: 35432693
[TBL] [Abstract][Full Text] [Related]
29. Editorial: The 2022 World Health Organization (WHO) Priority Recommendations and Response to the Omicron Variant (B.1.1.529) of SARS-CoV-2.
Parums DV
Med Sci Monit; 2022 Feb; 28():e936199. PubMed ID: 35102132
[TBL] [Abstract][Full Text] [Related]
30. Twice evasions of Omicron variants explain the temporal patterns in six Asian and Oceanic countries.
Chen B; Zhao Y; Jin Z; He D; Li H
BMC Infect Dis; 2023 Jan; 23(1):25. PubMed ID: 36639649
[TBL] [Abstract][Full Text] [Related]
31. Is Omicron the end of pandemic or start of a new innings?
Das S; Samanta S; Banerjee J; Pal A; Giri B; Kar SS; Dash SK
Travel Med Infect Dis; 2022; 48():102332. PubMed ID: 35472451
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous Screening of SARS-CoV-2 Omicron and Delta Variants Using High-Resolution Melting Analysis.
Aoki A; Mori Y; Okamoto Y; Jinno H
Biol Pharm Bull; 2022 Apr; 45(4):394-396. PubMed ID: 35067489
[TBL] [Abstract][Full Text] [Related]
33. Hotspots for SARS-CoV-2 Omicron variant spread: Lessons from New York City.
Ramírez JD; Castañeda S; Ballesteros N; Muñoz M; Hernández M; Banu R; Shrestha P; Chen F; Shi H; ; van Bakel H; Simon V; Cordon-Cardo C; Sordillo EM; Paniz-Mondolfi AE
J Med Virol; 2022 Jul; 94(7):2911-2914. PubMed ID: 35243662
[TBL] [Abstract][Full Text] [Related]
34. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
[TBL] [Abstract][Full Text] [Related]
35. The immune evasion ability of Delta variant is comparable to that of Beta variant in South Africa.
He D; Chen B; Zhao S; Stone L
BMC Public Health; 2023 Mar; 23(1):511. PubMed ID: 36927400
[TBL] [Abstract][Full Text] [Related]
36. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
Yang W; Shaman J
medRxiv; 2021 Nov; ():. PubMed ID: 34845460
[TBL] [Abstract][Full Text] [Related]
37. Generation of neutralizing antibodies against Omicron, Gamma and Delta SARS-CoV-2 variants following CoronaVac vaccination.
Silva ARD; Villas-Boas LS; Tozetto-Mendoza TR; Honorato L; Paula A; Witkin SS; Mendes-Correa MC
Rev Inst Med Trop Sao Paulo; 2022; 64():e19. PubMed ID: 35239863
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of infections with ancestral, Beta and Delta variants of SARS-CoV-2 in the PHIRST-C community cohort study, South Africa, 2020-2021.
Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit J; Gómez-Olivé FX; Dawood FS; Mkhencele T; ; Tempia S
BMC Infect Dis; 2024 Mar; 24(1):336. PubMed ID: 38515050
[TBL] [Abstract][Full Text] [Related]
39. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
[TBL] [Abstract][Full Text] [Related]
40. SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues.
Kim S; Nguyen TT; Taitt AS; Jhun H; Park HY; Kim SH; Kim YG; Song EY; Lee Y; Yum H; Shin KC; Choi YK; Song CS; Yeom SC; Kim B; Netea M; Kim S
Immune Netw; 2021 Dec; 21(6):e38. PubMed ID: 35036025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
